COVID-19Diagnostic testingMolecular detectionSARS-CoV-2SerodiagnosisSpecimen collectionSpecimen typesViral detectionThe diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ramifications on both an individual level and a public health level. The use of appropriate testing ...
As the country prepares to reopen, rapid and effective testing remains “the need of the hour.” In this episode, Dr. Pai discusses diagnostic testing for COVID-19, including which populations to prioritize for testing, available modalities and new options. Overview of symptoms1:05 A look at ...
Daniel Mbinda, the chairman of the KEMRI board of directors, said that currently, the institution is testing 70 percent of COVID-19 samples in the country, adding that the institution is looking at ways of partnering with the pharmaceutical industry to introduce new products to the local and ...
the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks...
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide. ...
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molec
As the new coronavirus continues to claim lives, the race is on to develop fast, convenient and accurate diagnostic tests for COVID-19. Now, researchers from CAS, a division of the American Chemical Society specializing in scientific information solution
The Pluslife Mini Dock is a portable, rapid molecular diagnostic system for COVID-19 and other infectious diseases, offering accurate results with easy home use.
For a detailed discussion of diagnostic testing of COVID-19, see (2), which suggests a number of diagnostics of the viral infection, none of which seems to have been used in the invaluable Viewpoint. It is well known that the purpose of any diagnostic test is to achieve high power, whi...
The performance of the test, called InspectIR COVID-19 Breathalyzer, was validated in a large study of 2,409 individuals, including those with and without symptoms. In the study, the test was shown to have 91.2 percent sensitivity and 99.3 percent specificity, according to the FDA. (Inspect...